BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Seddik H, Benass J, Berrag S, Sair A, Berraida R, Boutallaka H. Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori: A randomized clinical trial. World J Gastroenterol 2024; 30(6): 556-564 [PMID: 38463026 DOI: 10.3748/wjg.v30.i6.556]
URL: https://www.wjgnet.com/2220-3192/full/v30/i6/556.htm
Number Citing Articles
1
Tianlian Yan, Jinghua Wang, Renke Zhu, Dan Ma, Jianguo Gao, Jiewei Wang, Ye Chen, Kefang Sun, Qing Gu, Lan Li. Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trialJournal of Antimicrobial Chemotherapy 2025; 80(4): 927 doi: 10.1093/jac/dkae467
2
Jad Chidiac, Reine-Marie Kahwaji, Souheil Hallit, Yara Yazbeck, Bassem Akiki, Charbel Yazbeck. A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese PopulationCurrent Therapeutic Research 2025; 102: 100791 doi: 10.1016/j.curtheres.2025.100791